ArticleTrials2023

Urate-lowering therapy following a treat-to-target continuation strategy compared to a treat-to-avoid-symptoms discontinuation strategy in gout patients in remission (GO TEST Finale): study protocol of a multicentre pragmatic randomized superiority trial.

Iris Rose Peeters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.